Future Medicine Ltd., part of Future Science Group, UK, has announced the launch of a new bimonthly title - Neuropsychiatry. The journal will be published by Future Medicine Ltd (UK, London), known for its collection of journals providing healthcare practitioners and research professionals with a unique source of objective, cutting-edge information on exciting trends emerging in light of advances in medicine, healthcare and clinical practice.
Articles published in Neuropsychiatry will address all the latest trends in the field, from R&D through to clinical application and management, presenting research, findings, analysis and commentaries from experts around the world. The journal will cover a broad range of topics, from schizopherenia to anxiety disorders, Tourette's syndrome, late-life depression, pathophysiology, cognitive behavioral therapy, genetics, epidemiology and everything in between.
Neuropsychiatry will seek to provide concise and clear coverage of topics at the forefront of research, which impact the understanding and management of major neuropsychiatric disorders. Articles take the form of reviews, analysis and original articles which have undergone thorough peer review. The journal is projected as an ideal resource for all physicians and healthcare practitioners who are striving to provide the best possible evidence-based care for their patients also providing a preview of the research and issues on the horizon that are about to transform clinical practice.
Wayne Goodman of the Mount Sinai School of Medicine and Markus Leweke of the Central Institute for Mental Health, Germany, will be in charge of the editorial direction of Neuropsychiatry. They will be supported by a team of international experts making up the editorial advisory board.
Search for more Neuropsychiatry related Medical Journals
To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visit www.myscoope.com for a mobile friendly reading experience.
